Replies to post #335670 on Avid Bioservices Inc (CDMO)

[westjtter]

Yes I agree that $18 in the coming year is certainly achievable, but only if they start on their major expansion very very soon.

To achieve $18 they would need to significantly bump their current revenue and profit projections, and so far we have not seen or heard anything about new and larger contracts to achieve this revenue boost!

If the upcoming CC and financials are only going to be a platform to confirm their current guidance, we can kiss $18 per share good bye for a very long time.

Nick has to lay out how he plans on getting Avid to the "significantly larger" company he referred to and some indication of timelines to do so.

Being a manufacturing company, you cannot grow the company without winning significant and larger contracts which so far at least, we have heard nothing about. Does it mean they are in the works or they do not exist? Yet??

Of course I am also assuming that there are no more equipment malfunction snafus ahead of us(we never did get details of the last one).

The market is there for Avid, but they have to execute to achieve any kind of growth, and without that we will continue to operate in our current range of mediocracy.

We cannot move into the double digits(especially mid teens) without major contracts and growth!

Will they offer any plan along with increased guidance...or???

[ArchieK]

3's I share your desire for a more transparent and detailed communication of what's going on and was VERY disappointed in the ASM. Until I thought about it...after seeing the II's numbers. Retail (us) is an afterthought at this point and the communication is happening but straight to the few ears of those folks IMHO. While they have to do certain reporting legally I think they might be looking at communication to us as a pain/must-do and we might need to get used to it unless/until we can figure out other ways to see what's going on. I know IR is not that way, but maybe we can figure something out. All IMHO.